알파 리포산 시장 규모 : 제품별, 용도별 - 지역별 전망, 경쟁 전략, 부문별 예측(-2034년)

Alpha-lipoic Acid Market Introduction and Overview

According to SPER market research, 'Alpha-lipoic Acid Market Size- By Product, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Alpha-lipoic Acid Market is predicted to reach 973.31 million by 2034 with a CAGR of 6.49%.

Alpha-lipoic acid (ALA) is a naturally occurring chemical produced in the mitochondria and required for aerobic metabolism. It is a cofactor in enzymatic nutrient degradation and can be found in foods such as red meat, beets, carrots, potatoes, spinach, and broccoli. ALA is well-known for its strong antioxidant effects, which include scavenging reactive oxygen species and increasing tissue levels of other antioxidants such as glutathione. This dual effect has earned it the title "antioxidant of antioxidants.

Restraints: The global alpha-lipoic acid (ALA) market confronts various obstacles that could stymie its expansion. One key concern is a lack of product quality uniformity, which results in fluctuation and potential consumer distrust. This variability can lead to regulatory issues and customer confusion, as witnessed in similar areas such as eye health supplements. Furthermore, the market's fragmentation, with a large number of small and medium-sized competitors, limits prospects for collaboration and the formation of industry standards.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Application.

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Companies Covered

AlzChem Group AG, Bio Actives Japan Corporation, GeroNova Research Inc., Haihang Industry, K.-W. Pfannenschmidt GmbH, Olon S.p.A, Prinova Group LLC., Spectrum Chemical, Suzhou Fushilai Pharmaceutical Co. Ltd., Xi'an Green Spring Technology Co., Ltd, and Others.

Alpha-lipoic Acid Market Segmentation:

By Product: Based on the Product, Global Alpha-lipoic Acid Market is segmented as; R Alpha Lipoic Acid and S Alpha Lipoic Acid.

By Application: Based on the Application, Global Alpha-lipoic Acid Market is segmented as; Dietary Supplements, Cosmetics, Pharmaceuticals and Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPERs internal database
  • 2.1.4. Premium insight from KOLs
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTERs Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Alpha-lipoic Acid Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Alpha-lipoic Acid Market

7. Global Alpha-lipoic Acid Market, By Product, (USD Million) 2021-2034

• 7.1. R Alpha Lipoic Acid
• 7.2. S Alpha Lipoic Acid

8. Global Alpha-lipoic Acid Market, By Application (USD Million) 2021-2034

• 8.1. Dietary Supplements
• 8.2. Cosmetics
• 8.3. Pharmaceuticals
• 8.4. Others

9. Global Alpha-lipoic Acid Market, (USD Million) 2021-2034

• 9.1. Global Alpha-lipoic Acid Market Size and Market Share

10. Global Alpha-lipoic Acid Market, By Region, (USD Million) 2021-2034

• 10.1. Asia-Pacific
  • 10.1.1. Australia
  • 10.1.2. China
  • 10.1.3. India
  • 10.1.4. Japan
  • 10.1.5. South Korea
  • 10.1.6. Rest of Asia-Pacific
• 10.2. Europe
  • 10.2.1. France
  • 10.2.2. Germany
  • 10.2.3. Italy
  • 10.2.4. Spain
  • 10.2.5. United Kingdom
  • 10.2.6. Rest of Europe
• 10.3. Middle East and Africa
  • 10.3.1. Kingdom of Saudi Arabia
  • 10.3.2. United Arab Emirates
  • 10.3.3. Qatar
  • 10.3.4. South Africa
  • 10.3.5. Egypt
  • 10.3.6. Morocco
  • 10.3.7. Nigeria
  • 10.3.8. Rest of Middle-East and Africa
• 10.4. North America
  • 10.4.1. Canada
  • 10.4.2. Mexico
  • 10.4.3. United States
• 10.5. Latin America
  • 10.5.1. Argentina
  • 10.5.2. Brazil
  • 10.5.3. Rest of Latin America

11. Company Profile

• 11.1. AlzChem Group AG
  • 11.1.1. Company details
  • 11.1.2. Financial outlook
  • 11.1.3. Product summary
  • 11.1.4. Recent developments
• 11.2. Bio Actives Japan Corporation
  • 11.2.1. Company details
  • 11.2.2. Financial outlook
  • 11.2.3. Product summary
  • 11.2.4. Recent developments
• 11.3. GeroNova Research Inc.
  • 11.3.1. Company details
  • 11.3.2. Financial outlook
  • 11.3.3. Product summary
  • 11.3.4. Recent developments
• 11.4. Haihang Industry
  • 11.4.1. Company details
  • 11.4.2. Financial outlook
  • 11.4.3. Product summary
  • 11.4.4. Recent developments
• 11.5. K.-W. Pfannenschmidt GmbH
  • 11.5.1. Company details
  • 11.5.2. Financial outlook
  • 11.5.3. Product summary
  • 11.5.4. Recent developments
• 11.6. Olon S.p.A
  • 11.6.1. Company details
  • 11.6.2. Financial outlook
  • 11.6.3. Product summary
  • 11.6.4. Recent developments
• 11.7. Prinova Group LLC.
  • 11.7.1. Company details
  • 11.7.2. Financial outlook
  • 11.7.3. Product summary
  • 11.7.4. Recent developments
• 11.8. Spectrum Chemical
  • 11.8.1. Company details
  • 11.8.2. Financial outlook
  • 11.8.3. Product summary
  • 11.8.4. Recent developments
• 11.9. Suzhou Fushilai Pharmaceutical Co. Ltd.
  • 11.9.1. Company details
  • 11.9.2. Financial outlook
  • 11.9.3. Product summary
  • 11.9.4. Recent developments
• 11.10. Xian Green Spring Technology Co., Ltd
  • 11.10.1. Company details
  • 11.10.2. Financial outlook
  • 11.10.3. Product summary
  • 11.10.4. Recent developments

12. Conclusion

13. List of Abbreviations

14. Reference Links